PPD Clinical Research Associates recognized for excellence
Pharmaceutical Product Development (PPD) announced industry accolades earned by PPD clinical research associates (CRAs), recognizing their expertise in the endeavor of developing life-changing medicines.
A four-person team of PPD CRAs won the gold award for Clinical Research Team of the Year at the PharmaTimes International Clinical Researcher of the Year in London. And at the PharmaTimes Clinical Researcher of the Year—The Americas competition, two PPD CRAs were honored in Seattle, Washington. Both competitions were a culmination of a demanding year long, three-part series of tests, including real-life challenges judged by industry leaders.
The industry recognition demonstrates the high caliber of PPD’s CRAs and PPD’s award-winning training and development programs, such as the Virtual Clinical Foundations Program 2.0, which help to prepare research professionals for successful clinical trial monitoring, and to deliver performance, quality and value to clients and their studies.
“PPD’s clinical researchers are focused on and dedicated to providing the best for their clinical trials and our clients,” said Roger Newbery, senior vice president of Clinical Management for PPD. “I am proud that their talent and hard work has been recognized in this way.”
In London, the PPD team was awarded gold at the event finale on May 18. At the celebration in Seattle, the PPD CRAs received the gold award in the Experienced CRA category and the bronze award in the New CRA category. The event was created in 1999 to provide clinical research professionals an opportunity to benchmark their professional skills against their peers in a program of competency-based exercises developed through cross-industry collaboration.